Rx Medical Food Market Set for Rapid Growth And Trend by 2026 With Key Vendors : Abbott Laboratories, Danone, Mead Johnson & Company, LLC, Fresenius Kabi AG, Nestle, Primus Pharmaceuticals, Inc.

Rx Medical Food Market was valued at US$ 14,504.6 million in 2016 and is projected to exhibit a CAGR of 7.0% over the forecast period (2018–2026), as highlighted in a new report published by Coherent Market Insights. Growing regulatory support, increasing awareness about medical food in emerging economies and advantages over drug therapies are expected to be the major factors driving growth of the global Rx medical food market over the forecast period.

Get PDF Brochure of Research Report: www.coherentmarketinsights.com/insight/request-pdf/909

"Rx Medical Food Market to Surpass US$ 26,455.7 Million Threshold by 2025 Globally On Account of Increasing Regulatory Support"

Manufacturers are developing medical food products with improved therapeutic effects and different dosage forms for ease of administration and patient convenience. Abbott laboratories introduced science-based nutrition drinks, Ensure Surgery Immunonutrition Shake, and Ensure Pre Surgery Clear Nutrition in 2016, to help patients recover from surgeries. Cera Products, Inc. launched Ceralyte oral rehydration salt to treat dehydration and diarrhea in 2017. Cambrooke announced the launch of Tylacti COMPLETE Bars, a nutritionally complete medical food available in a convenient format, for the dietary management of Tyrosinemia (TYR) in 2017. The company launched medical food line Phenactin AA Plus, Vilactin AA Plus, Isovactin AA Plus, Homactin AA Plus, and Promactin AA Plus for inborn errors of metabolism in 2015. Nutricia Metabolics launched Anamix Next for Tyrosinemia, Methylmalonic Acidemia, and Isovaleric Acidemia in 2015. Moreover, the company launched PhenylAde GMP, a new formula for Phenylketonuria (PKU) in the same year.

Key players are investing in research and development activities of pipeline products for the development of novel medical food that can be used in various medical conditions. For instance, in 2012, Targeted Medical Pharma reported preliminary data of its new amino acid-based oral formulation called PERCURA, which can be used for reducing symptoms of pain and numbness associated with peripheral neuropathy, in an open-label pilot study. In 2015, Enzymotec Ltd announced investigator initiated clinical trial of Vayarin, which is capable of managing attention deficit hyperactivity disorder (ADHD) in children suffering from epilepsy. Moreover, scientists at Nestlé Institute of Health Science are studying human DNA for the development of personalized programs for epilepsy and intestinal disorders, thereby leading to development of medical food products that contain natural compounds.

Major players are adopting strategies such as mergers and acquisitions to expand their product portfolio and enter into the medical food industry. Nestlé is adding medical foods such as prescription-based powders and drinks that can be used for treatment of diseases to its existing product portfolio for business expansion, which will in turn help the company to enter the nutrition sector. In 2017, AlfaSigma, an Italy-based company completed the acquisition of the U.S. medical food maker Pamlab from Nestlé, to strengthen the company’s operations in North America. The U.S. Food & Drug Administration (FDA) awarded grants through the Orphan Products Clinical Trials Grants Program, to encourage clinical development of products, which includes medical food to treat rare diseases or conditions.

Speak to Analyst before Purchase This Report: www.coherentmarketinsights.com/insight/talk-to-analyst/909

Key Takeaways of the Rx Medical Food Market:

-The global Rx medical food market is expected to exhibit a CAGR of 0% over the forecast period (2017–2025), owing to the presence of high potential, especially in Asia Pacific, Latin America, the Middle East, and Africa
-Novel product developments for varying disease conditions and increasing awareness about the health benefits of medical food is expected to drive growth of the global Rx medical food market
-The U.S. congress has passed a National Defense Authorization Act in 2017, to cover costs of medical food under Tricare (military healthcare). This step is expected to support patients suffering from medical conditions and consuming medical food. This category was previously not covered for reimbursement under prescription drug plans.
-Some major players operating in the Rx medical food market include Abbott Laboratories, Danone, Mead Johnson & Company, LLC, Fresenius Kabi AG, Nestle, Primus Pharmaceuticals, Inc., Targeted Medical Pharma, Enzymotec ltd., AlfaSigma, and Pivotal Therapeutics.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentMarketinsights.com

This release was published on openPR.